Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
2.6M
-
Shares change
-
-31.1K
-
Total reported value, excl. options
-
$221M
-
Value change
-
-$2.72M
-
Number of buys
-
29
-
Number of sells
-
-39
-
Price
-
$85.04
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q2 2021
82 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q2 2021.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.6M shares
of 3.2M outstanding shares and own 81.13% of the company stock.
Largest 10 shareholders include FMR LLC (536K shares), PRICE T ROWE ASSOCIATES INC /MD/ (282K shares), RENAISSANCE TECHNOLOGIES LLC (244K shares), BlackRock Inc. (225K shares), VANGUARD GROUP INC (194K shares), DIMENSIONAL FUND ADVISORS LP (152K shares), RICE HALL JAMES & ASSOCIATES, LLC (113K shares), JPMORGAN CHASE & CO (96.6K shares), Russell Investments Group, Ltd. (82.6K shares), and STATE STREET CORP (66.1K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.